Clarus Defined Exit I, L.P.

Insider Reports History

Location
Cambridge, MA
Signature
CLARUS DEFINED EXIT I, L.P., By: Clarus Ventures DE GP, L.P., its GP, By: Blackstone Clarus DE L.L.C., its GP, By: Blackstone Holdings II L.P., its sole member, By: Blackstone Holdings I/II GP L.L.C., its GP, By: /s/ Tabea Hsi, Senior Managing Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Clarus Defined Exit I, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Talaris Therapeutics, Inc. 10%+ Owner Common Stock 160,044 $2,719,148 $16.99 11 May 2021 Indirect
Talaris Therapeutics, Inc. 10%+ Owner Series A-1 Convertible Preferred Stock 0 11 May 2021 Indirect
Talaris Therapeutics, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 11 May 2021 Indirect
Talaris Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 11 May 2021 Indirect

Insider Reports Filed by Clarus Defined Exit I, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRML Talaris Therapeutics, Inc. 11 May 2021 33 +$510,000 4 10%+ Owner 13 May 2021, 21:59